VRTX · earnings call history
Vertex Pharmaceuticals Q2 FY26 — Strong Commercial Momentum and Strategic Expansion
Read the briefVertex Pharmaceuticals Q1 FY26 — Strong Growth Across Portfolio and Rapid Pipeline Advancement
Read the briefVertex Pharmaceuticals Q4 FY25 — Strong Diversification and Pipeline Progress
Read the briefVertex Pharmaceuticals Q3 FY25 — Strong Revenue Growth and Pipeline Advancement
Read the briefVertex Pharmaceuticals Q2 FY25 — Strong Revenue Growth and Pipeline Advancement
Read the briefVertex Pharmaceuticals Q1 FY25 — Strong Launch Momentum and Pipeline Advancement
Read the briefVertex Q4 FY24 — Strong CF Growth, New Product Launches, and Pipeline Advancement
Read the briefBrowse all US companies on the earnings-call register.